Hyperopia and Presbyopia Management

Introduction to Hyperopia and Presbyopia Treatment

The primary treatment options for hyperopia include eyeglasses, contact lenses, and refractive surgery, with eyeglasses being the first-line treatment due to their simplicity, effectiveness, and safety profile 1
For children with esotropia, the threshold for prescribing hyperopic eyeglasses is lower, generally +1.00D or more of hyperopia 2
Impact-resistant lenses are preferable for children, especially those with amblyopia 2
Presbyopia affects approximately 1.8 billion people worldwide, with over half lacking adequate presbyopic correction, and untreated presbyopia negatively affecting quality of life and workplace productivity 1

Eyeglasses are the cornerstone of hyperopia management, with prescription considerations including slight undercorrection for young and middle-aged individuals, and full correction for older individuals to provide optimal distance vision and minimize difficulties with near vision 1
Contact lenses are an effective alternative to eyeglasses, requiring less accommodative effort for hyperopic patients, and options include soft contact lenses, rigid gas-permeable lenses, multifocal contact lenses, and monovision contact lenses 1
Patients whose primary correction is contact lenses should have a backup pair of eyeglasses to reduce risk of contact lens overwear and avoid lens use when the eye is inflamed 1
Reading glasses, bifocal lenses, trifocal lenses, and progressive lenses are available options for presbyopia correction, with progressive lenses providing a gradual change in power from top to bottom without visible lines 3, 1
Multifocal contact lenses, monovision contact lenses, and modified monovision are also available for presbyopia management, providing simultaneous vision for distance and near, or correcting one eye for distance and the other for near 3, 1

Surgical options for hyperopia include corneal refractive procedures such as LASIK, PRK, LASEK, and Epi-LASIK, as well as lens-based procedures like clear lens extraction and phakic intraocular lens implantation 1
Excimer laser photoablation, including PRK, LASEK, epi-LASIK, LASIK, and refractive lenticule extraction, is a widely used surgical approach for presbyopia correction 3
Monovision correction, where the dominant eye is corrected for distance and the non-dominant eye is corrected for near, is a surgical option for presbyopia, but may reduce contrast sensitivity and stereopsis 3
Refractive lens exchange, including removal of the crystalline lens with IOL implantation, is a surgical option for presbyopia, with various IOL options available, including monofocal, multifocal, accommodative, extended depth of focus, light-adjustable, and toric IOLs 3

Regular comprehensive eye examinations are recommended, with frequencies varying by age: every 5-10 years for patients under 40, every 2-4 years for patients 40-54, every 1-3 years for patients 55-64, and every 1-2 years for patients 65 or older 1
Contact lens wearers should have examinations every 1-2 years to monitor for adverse effects 1
Initial assessment of patients with presbyopia should determine visual needs, lifestyle, and occupational requirements, as well as assess ocular health, including retinal examination 3
Preoperative testing for surgical candidates should include monovision trial with contact lenses, dominant eye testing, and thorough ocular examination, including corneal topography and retinal evaluation 3

When hyperopia coexists with presbyopia, options include bifocals, trifocals, progressive lenses, or separate glasses for different distances, as well as multifocal or monovision contact lenses, and surgical options like monovision correction or multifocal intraocular lenses 1
Moderate-to-high hyperopia significantly increases the risk for amblyopia and strabismus, and early detection and treatment may prevent complications 2
The American Academy of Ophthalmology recommends eyeglasses, contact lenses, and FDA-approved pilocarpine 1.25% (Vuity) as primary first-line options for most patients with presbyopia 3, 1
Pilocarpine HCL 1.25% (Vuity) is an FDA-approved topical therapy that works by stimulating ciliary muscle contraction and miosis, but carries a risk of retinal detachment and retinal tear, and requires a dilated fundus examination prior to initiation 3, 1
Patients should understand that compromise is often necessary between distance and near vision, and that no current solution fully overcomes presbyopia in all patients 1